首页> Clinical and vaccine immunology : CVI> Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.

导出 OA

翻译打印收藏纠错

第一作者： Sharon E,Frey

第一单位： Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA freyse@slu.edu.

作者： Sharon E,Frey ^[1] ; Laurence,Peiperl ^[2] ; M Juliana,McElrath ^[3] ; Spyros,Kalams ^[4] ; Paul A,Goepfert ^[5] ; Michael C,Keefer ^[6] ; Lindsey R,Baden ^[7] ; Michelle A,Lally ^[8] ; Kenneth,Mayer ^[9] ; William A,Blattner ^[10] ; Clayton D,Harro ^[11] ; Scott M,Hammer ^[12] ; Geoffrey J,Gorse ^[13] ; John,Hural ^[14] ; Georgia D,Tomaras ^[15] ; Yves,Levy ^[16] ; Peter,Gilbert ^[17] ; Allan,deCamp ^[17] ; Nina D,Russell ^[18] ; Marnie,Elizaga ^[14] ; Mary,Allen ^[19] ; Lawrence,Corey ^[3]

作者单位： Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA freyse@slu.edu. ^[1] Department of Medicine, University of California, San Francisco, California, USA. ^[2] Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington, USA. ^[3] Vanderbilt University School of Medicine, Nashville, Tennessee, USA. ^[4] Department of Medicine, University of Alabama, Birmingham, Alabama, USA. ^[5] Department of Medicine, University of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA. ^[6] Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. ^[7] Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA. ^[8] The Fenway Institute, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA. ^[9] Institute of Human Virology, University of Maryland, Baltimore, Maryland, USA. ^[10] Center for Immunization Research, Johns Hopkins University, Baltimore, Maryland, USA. ^[11] Department of Medicine, Columbia University Medical Center, New York, New York, USA. ^[12] Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA. ^[13] Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[14] Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA. ^[15] Inserm, U955, Equipe 16, Université Paris Est, Faculté de Médecine, Vaccine Research Institute (VRI), Créteil, France. ^[16] SCHARP Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[17] Bill & Melinda Gates Foundation, Seattle, Washington, USA. ^[18] AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. ^[19]